Advertisement

Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience

  • Jacob S. Ghannam
  • Michael R. Cline
  • Anthony N. Hage
  • Jeffrey Forris Beecham Chick
  • Rajiv N. Srinivasa
  • Narasimham L. Dasika
  • Ravi N. Srinivasa
  • Joseph J. Gemmete
Original Article

Abstract

Background

Transjugular intrahepatic portosystemic shunt (TIPS) placement has been extensively studied in adults. The experience with TIPS placement in pediatric patients, however, is limited.

Objective

The purpose of this study was to report technical success and clinical outcomes in pediatric patients undergoing TIPS placement.

Materials and methods

Twenty-one children — 12 (57%) boys and 9 (43%) girls, mean age 12.1 years (range, 2–17 years) — underwent TIPS placement from January 1997 to January 2017. Etiologies of hepatic dysfunction included biliary atresia (n=5; 24%), cryptogenic cirrhosis (n=4; 19%), portal or hepatic vein thrombosis (n=4, 14%), autosomal-recessive polycystic kidney disease (n=3; 14%), primary sclerosing cholangitis (n=2; 10%) and others (n=3, 14%). Indications for TIPS placement included variceal hemorrhage (n=20; 95%) and refractory ascites (n=1; 5%). Technical success, manometry findings, stent type, hemodynamic success, complications, liver enzymes, and clinical outcomes were recorded.

Results

TIPS placement was technically successful in 20 of 21 (95%) children, with no immediate complications. Mean pre- and post-TIPS portosystemic gradient was 18.5±10.7 mmHg and 7.1±3.9 mmHg, respectively. Twenty-two total stents were successfully placed in 20 children. Stents used included: Viatorr (n=9; 41%), Wallstent (n=7; 32%), Express (n=5; 23%), and iCAST (n=1; 5%). All children had resolution of variceal bleeding or ascites. TIPS revision was required in 9 (45%) children, with a mean of 2.2 revisions. Hepatic encephalopathy developed in 10 children (48%), at a mean of 223.7 days following TIPS placement. During the study, 6 (29%) children underwent liver transplantation.

Conclusion

TIPS placement in pediatric patients has high technical success with excellent resolution of variceal hemorrhage and ascites. TIPS revision was required in nearly half of the cohort, with hepatic encephalopathy common after shunt placement.

Keywords

Children Interventional radiology Liver Portal hypertension Stent Transjugular intrahepatic portosystemic shunt 

Notes

Compliance with ethical standards

Conflicts of interest

None

References

  1. 1.
    Garcia-Pagan JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–2379CrossRefGoogle Scholar
  2. 2.
    Salerno F, Merli M, Riggio O et al (2004) Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 40:629–635CrossRefGoogle Scholar
  3. 3.
    Toomey PG, Ross SB, Golkar FC et al (2013) Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere. Am J Surg 205:441–446CrossRefGoogle Scholar
  4. 4.
    Dariushnia SR, Haskal ZJ, Midia M et al (2016) Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 27:1–7CrossRefGoogle Scholar
  5. 5.
    Boyer TD, Haskal ZJ (2005) American Association for the Study of Liver Diseases practice guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 16:615–629CrossRefGoogle Scholar
  6. 6.
    Di Giorgio A, Agazzi R, Alberti D et al (2012) Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children. J Pediatr Gastroenterol Nutr 54:594–600CrossRefGoogle Scholar
  7. 7.
    Hackworth CA, Leef JA, Rosenblum JD et al (1998) Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology 206:109–114CrossRefGoogle Scholar
  8. 8.
    Huppert PE, Goffette P, Astfalk W et al (2002) Transjugular intrahepatic portosystemic shunts in children with biliary atresia. Cardiovasc Intervent Radiol 25:484–493CrossRefGoogle Scholar
  9. 9.
    Yoeli D, Galvan NTN, Ashton DJ et al (2017) Portosystemic shunt as a bridge to liver transplantation in infants: a comparison of two techniques. Pediatr Transplant 21:e12915CrossRefGoogle Scholar
  10. 10.
    Bavdekar A, Thakur N (2016) Ascites in children. Indian J Pediatr 83:1334–1340CrossRefGoogle Scholar
  11. 11.
    McKiernan P, Abdel-Hady M (2015) Advances in the management of childhood portal hypertension. Expert Rev Gastroenterol Hepatol 9:575–583CrossRefGoogle Scholar
  12. 12.
    Hanauer DA, Mei Q, Law J et al (2015) Supporting information retrieval from electronic health records: a report of University of Michigan’s nine year experience in developing and using the electronic medical record search engine (EMERSE). J Biomed Inform 55:290–300CrossRefGoogle Scholar
  13. 13.
    Omary RA, Bettmann MA, Cardella JF et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293–S295CrossRefGoogle Scholar
  14. 14.
    Khalilzadeh O, Baerlocher MO, Shyn PB et al (2017) Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of practice committee. J Vasc Interv Radiol 28:1432–1437 e3CrossRefGoogle Scholar
  15. 15.
    Zurera LJ, Espejo JJ, Lombardo S et al (2015) Safety and efficacy of expanded polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts in children with acute or recurring upper gastrointestinal bleeding. Pediatr Radiol 45:422–429CrossRefGoogle Scholar
  16. 16.
    Lv Y, He C, Guo W et al (2016) Transjugular intrahepatic portosystemic shunt for extrahepatic portal venous obstruction in children. J Pediatr Gastroenterol Nutr 62:233–241CrossRefGoogle Scholar
  17. 17.
    Heyman MB, LaBerge JM, Somberg KA et al (1997) Transjugular intrahepatic portosystemic shunts (TIPS) in children. J Pediatr 131:914–919CrossRefGoogle Scholar
  18. 18.
    Sahagun G, Benner KG, Saxon R et al (1997) Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol 92:1444–1452PubMedGoogle Scholar
  19. 19.
    Biecker E, Roth F, Heller J et al (2007) Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Eur J Gastroenterol Hepatol 19:846–852CrossRefGoogle Scholar
  20. 20.
    Yang Z, Han G, Wu Q et al (2010) Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 25:1718–1725CrossRefGoogle Scholar
  21. 21.
    Rossle M, Siegerstetter V, Euringer W et al (2006) The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients. Acta Radiol 47:660–666CrossRefGoogle Scholar
  22. 22.
    Vo NJ, Shivaram G, Andrews RT et al (2012) Midterm follow-up of transjugular intrahepatic portosystemic shunts using polytetrafluoroethylene endografts in children. J Vasc Interv Radiol 23:919–924CrossRefGoogle Scholar
  23. 23.
    Qin JP, Jiang MD, Tang W et al (2013) Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol 19:8085–8092CrossRefGoogle Scholar
  24. 24.
    Van Ha TG, Funaki BS, Ehrhardt J et al (2005) Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. AJR Am J Roentgenol 184:920–925CrossRefGoogle Scholar
  25. 25.
    Lorenz JM (2008) Placement of transjugular intrahepatic portosystemic shunts in children. Tech Vasc Interv Radiol 11:235–240CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jacob S. Ghannam
    • 1
  • Michael R. Cline
    • 1
  • Anthony N. Hage
    • 1
  • Jeffrey Forris Beecham Chick
    • 1
    • 2
  • Rajiv N. Srinivasa
    • 1
  • Narasimham L. Dasika
    • 1
  • Ravi N. Srinivasa
    • 1
    • 3
  • Joseph J. Gemmete
    • 1
  1. 1.Department of Radiology, Division of Vascular and Interventional RadiologyUniversity of Michigan Health SystemAnn ArborUSA
  2. 2.Cardiovascular and Interventional RadiologyInova Alexandria HospitalAlexandriaUSA
  3. 3.Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, Ronald Reagan Medical Center at UCLADavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations